64 related articles for article (PubMed ID: 19758474)
1. Differential uptake and selective permeability of fusarochromanone (FC101), a novel membrane permeable anticancer naturally fluorescent compound in tumor and normal cells.
Furmanski BD; Dréau D; Wuthier RE; Fuseler JW
Microsc Microanal; 2009 Dec; 15(6):545-57. PubMed ID: 19758474
[TBL] [Abstract][Full Text] [Related]
2. Cytoskeleton alterations induced by Geodia corticostylifera depsipeptides in breast cancer cells.
Rangel M; Prado MP; Konno K; Naoki H; Freitas JC; Machado-Santelli GM
Peptides; 2006 Sep; 27(9):2047-57. PubMed ID: 16843570
[TBL] [Abstract][Full Text] [Related]
3. Distribution of furamidine analogues in tumor cells: targeting of the nucleus or mitochondria depending on the amidine substitution.
Lansiaux A; Tanious F; Mishal Z; Dassonneville L; Kumar A; Stephens CE; Hu Q; Wilson WD; Boykin DW; Bailly C
Cancer Res; 2002 Dec; 62(24):7219-29. PubMed ID: 12499262
[TBL] [Abstract][Full Text] [Related]
4. Biological activities of fusarochromanone: a potent anti-cancer agent.
Mahdavian E; Palyok P; Adelmund S; Williams-Hart T; Furmanski BD; Kim YJ; Gu Y; Barzegar M; Wu Y; Bhinge KN; Kolluru GK; Quick Q; Liu YY; Kevil CG; Salvatore BA; Huang S; Clifford JL
BMC Res Notes; 2014 Sep; 7():601. PubMed ID: 25187308
[TBL] [Abstract][Full Text] [Related]
5. Dose response of human tumor cells to rhodamine 123 and laser phototherapy.
Saxton RE; Haghighat S; Plant D; Lufkin R; Soudant J; Castro DJ
Laryngoscope; 1994 Aug; 104(8 Pt 1):1013-8. PubMed ID: 8052065
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines.
Lehmann J; Retz M; Sidhu SS; Suttmann H; Sell M; Paulsen F; Harder J; Unteregger G; Stöckle M
Eur Urol; 2006 Jul; 50(1):141-7. PubMed ID: 16476519
[TBL] [Abstract][Full Text] [Related]
7. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.
Brewer M; Wharton JT; Wang J; McWatters A; Auersperg N; Gershenson D; Bast R; Zou C
Gynecol Oncol; 2005 Aug; 98(2):182-92. PubMed ID: 15907982
[TBL] [Abstract][Full Text] [Related]
8. Estradiol attenuates mitochondrial depolarization in polyol-stressed lens epithelial cells.
Flynn JM; Cammarata PR
Mol Vis; 2006 Apr; 12():271-82. PubMed ID: 16617294
[TBL] [Abstract][Full Text] [Related]
9. Imatinib mesylate inhibits proliferation and exerts an antifibrotic effect in human breast stroma fibroblasts.
Gioni V; Karampinas T; Voutsinas G; Roussidis AE; Papadopoulos S; Karamanos NK; Kletsas D
Mol Cancer Res; 2008 May; 6(5):706-14. PubMed ID: 18505916
[TBL] [Abstract][Full Text] [Related]
10. CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy.
Bao R; Lai CJ; Qu H; Wang D; Yin L; Zifcak B; Atoyan R; Wang J; Samson M; Forrester J; DellaRocca S; Xu GX; Tao X; Zhai HX; Cai X; Qian C
Clin Cancer Res; 2009 Jun; 15(12):4046-57. PubMed ID: 19509149
[TBL] [Abstract][Full Text] [Related]
11. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells.
Izbicka E; Wheelhouse RT; Raymond E; Davidson KK; Lawrence RA; Sun D; Windle BE; Hurley LH; Von Hoff DD
Cancer Res; 1999 Feb; 59(3):639-44. PubMed ID: 9973212
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of fusarochromanone on melanoma growth.
Dréau D; Foster M; Hogg M; Culberson C; Nunes P; Wuthier RE
Anticancer Drugs; 2007 Sep; 18(8):897-904. PubMed ID: 17667595
[TBL] [Abstract][Full Text] [Related]
13. Potential of traditional ayurvedic formulation, Triphala, as a novel anticancer drug.
Sandhya T; Lathika KM; Pandey BN; Mishra KP
Cancer Lett; 2006 Jan; 231(2):206-14. PubMed ID: 15899544
[TBL] [Abstract][Full Text] [Related]
14. Differential influence of normal and cancer-associated fibroblasts on the growth of human epithelial cells in an in vitro cocultivation model of prostate cancer.
Paland N; Kamer I; Kogan-Sakin I; Madar S; Goldfinger N; Rotter V
Mol Cancer Res; 2009 Aug; 7(8):1212-23. PubMed ID: 19671672
[TBL] [Abstract][Full Text] [Related]
15. A protein-permeable scaffold of a collagen vitrigel membrane useful for reconstructing crosstalk models between two different cell types.
Takezawa T; Nitani A; Shimo-Oka T; Takayama Y
Cells Tissues Organs; 2007; 185(1-3):237-41. PubMed ID: 17587830
[TBL] [Abstract][Full Text] [Related]
16. Novel ceramide analogues display selective cytotoxicity in drug-resistant breast tumor cell lines compared to normal breast epithelial cells.
Crawford KW; Bittman R; Chun J; Byun HS; Bowen WD
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1017-23. PubMed ID: 14682383
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
18. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis.
Qaddoumi MG; Gukasyan HJ; Davda J; Labhasetwar V; Kim KJ; Lee VH
Mol Vis; 2003 Oct; 9():559-68. PubMed ID: 14566223
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein-independent apoptosis induction by a novel synthetic compound, MMPT [5-[(4-methylphenyl)methylene]-2-(phenylamino)-4(5H)-thiazolone].
Teraishi F; Wu S; Sasaki J; Zhang L; Zhu HB; Davis JJ; Fang B
J Pharmacol Exp Ther; 2005 Jul; 314(1):355-62. PubMed ID: 15831436
[TBL] [Abstract][Full Text] [Related]
20. Expression of S100P protein correlates with and contributes to the tumorigenic capacity of HeLa cervical carcinoma cells.
Gibadulinová A; Baráthová M; Kopácek J; Hulíková A; Pastoreková S; Kettmann R; Pastorek J
Oncol Rep; 2005 Aug; 14(2):575-82. PubMed ID: 16012747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
